Mealey's (March 22, 2018, 1:01 PM EDT) -- ST. LOUIS — The U.S. Supreme Court’s recent ruling in Bristol-Myers Squibb Co. v. Superior Court of California did not extend the 30-day period in which the makers of Risperdal could remove a products liability suit, a federal judge in Missouri ruled March 20 in remanding the suit to state court (Dolphin Moody, et al. v. Janssen Pharmaceuticals Inc., et al., No. 17CV2029 HEA, E.D. Mo., 2018 U.S. Dist. LEXIS 45270)....